Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systems.

Suppr

超能文献

作者信息

Singh N, Ayhan A, Menon U, Chin Aleong J A, Faruqi A Z, Gayther S A, Jacobs I J

出版信息

Histopathology. 2008 Feb;52(3):393-5. doi: 10.1111/j.1365-2559.2007.02912.x. Epub 2007 Dec 13.

DOI:10.1111/j.1365-2559.2007.02912.x

PMID:18081817

Abstract

摘要

相似文献

Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systems.

Histopathology. 2008 Feb;52(3):393-5. doi: 10.1111/j.1365-2559.2007.02912.x. Epub 2007 Dec 13.

Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.卵巢浆液性癌分级的两级系统的观察者间及观察者内变异性

Am J Surg Pathol. 2007 Aug;31(8):1168-74. doi: 10.1097/PAS.0b013e31803199b0.

[Clinical significance of two-tier grading system of ovarian serous carcinoma].[卵巢浆液性癌两级分级系统的临床意义]

Zhonghua Fu Chan Ke Za Zhi. 2011 Oct;46(10):739-41.

Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.具有透明细胞和浆液性成分的混合性卵巢上皮癌是高级别浆液性癌的变体：32例病例的观察者间相关性及免疫组织化学研究

Am J Surg Pathol. 2008 Jul;32(7):955-64. doi: 10.1097/PAS.0b013e318164edf7.

Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data.基于分子遗传学和体外耐药性数据，将卵巢和腹膜浆液性癌细分为中分化和低分化没有生物学依据。

Am J Surg Pathol. 2008 Nov;32(11):1667-74. doi: 10.1097/PAS.0b013e31816fd555.

[Updates on histologic grading and pathogenesis of ovarian serous carcinomas].[卵巢浆液性癌的组织学分级及发病机制的最新进展]

Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):507-10.

Two-tier grading system for ovarian epithelial cancer: has its time arrived?卵巢上皮癌的两级分级系统：其时代已经到来了吗？

Am J Surg Pathol. 2007 Aug;31(8):1285-7. doi: 10.1097/PAS.0b013e318030616f.

Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.

J Obstet Gynaecol Res. 2007 Feb;33(1):95-9. doi: 10.1111/j.1447-0756.2007.00488.x.

The role of immunohistochemistry in differentiating between peritoneal mesothelioma and ovarian serous carcinoma.免疫组织化学在鉴别腹膜间皮瘤和卵巢浆液性癌中的作用。

Saudi Med J. 2009 Apr;30(4):571-4.

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.肿瘤细胞类型能够被重复性诊断，并且在接受最大程度肿瘤细胞减灭术的卵巢癌患者中具有独立的预后意义。

Hum Pathol. 2008 Aug;39(8):1239-51. doi: 10.1016/j.humpath.2008.01.003. Epub 2008 Jul 7.

引用本文的文献

EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.EphA5蛋白，一种用于区分卵巢浆液性癌组织学分级和预后的潜在标志物。

J Ovarian Res. 2016 Nov 25;9(1):83. doi: 10.1186/s13048-016-0292-1.

Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.国际妇产科联盟（FIGO）I-II期上皮性卵巢癌中I型和II型肿瘤的临床及生物学特征差异

Int J Gynecol Cancer. 2015 Sep;25(7):1239-47. doi: 10.1097/IGC.0000000000000484.

[Histological grading of epithelial ovarian cancer. Review and recommendation].[上皮性卵巢癌的组织学分级。综述与建议]

Pathologe. 2014 Sep;35(5):497-503. doi: 10.1007/s00292-014-1948-5.

Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).采用三种广泛使用的分级系统对大量晚期卵巢癌进行组织学分级：始终缺乏预后意义。一项前瞻性随机III期研究（AGO-OVAR 3方案）的转化研究子方案。

Virchows Arch. 2009 Mar;454(3):249-56. doi: 10.1007/s00428-009-0725-y. Epub 2009 Jan 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验